191 related articles for article (PubMed ID: 8863389)
1. Myelopoiesis and myeloproliferative disorders.
Raskin RE
Vet Clin North Am Small Anim Pract; 1996 Sep; 26(5):1023-42. PubMed ID: 8863389
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML) and chronic myeloproliferative disorder (CMPD) in cats.
Breuer W; Hermanns W; Thiele J
J Comp Pathol; 1999 Oct; 121(3):203-16. PubMed ID: 10486157
[TBL] [Abstract][Full Text] [Related]
3. Myeloproliferative disease in the dog and cat: definition, aetiology and classification.
Evans RJ; Gorman NT
Vet Rec; 1987 Nov; 121(19):437-43. PubMed ID: 3424614
[TBL] [Abstract][Full Text] [Related]
4. Suspected myelodysplastic/myeloproliferative neoplasm in a feline leukemia virus-negative cat.
Weeden AL; Taylor KR; Terrell SP; Gallagher AE; Wamsley HL
Vet Clin Pathol; 2016 Dec; 45(4):584-593. PubMed ID: 27870069
[TBL] [Abstract][Full Text] [Related]
5. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocytic myelosis in a cat.
Michel RL; O'Handley P; Dade AW
J Am Vet Med Assoc; 1976 Jun; 168(11):1021-5. PubMed ID: 931768
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
9. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
[TBL] [Abstract][Full Text] [Related]
10. Feline myeloproliferative disease. Changing manifestations in the peripheral blood.
Harvey JW; Shields RP; Gaskin JM
Vet Pathol; 1978 Jul; 15(4):437-48. PubMed ID: 695218
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
Stevens EC; Rosenthal NS
Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
[TBL] [Abstract][Full Text] [Related]
13. A hematological study on thirteen cats with myelodysplastic syndrome.
Shimoda T; Shiranaga N; Mashita T; Hasegawa A
J Vet Med Sci; 2000 Jan; 62(1):59-64. PubMed ID: 10676891
[TBL] [Abstract][Full Text] [Related]
14. Myeloproliferative disorders.
Young KM
Vet Clin North Am Small Anim Pract; 1985 Jul; 15(4):769-81. PubMed ID: 3898534
[TBL] [Abstract][Full Text] [Related]
15. Proposed criteria for classification of acute myeloid leukemia in dogs and cats.
Jain NC; Blue JT; Grindem CB; Harvey JW; Kociba GJ; Krehbiel JD; Latimer KS; Raskin RE; Thrall MA; Zinkl JG
Vet Clin Pathol; 1991; 20(3):63-82. PubMed ID: 12673541
[TBL] [Abstract][Full Text] [Related]
16. Long-term case study of myelodysplastic syndrome in a dog.
Miyamoto T; Horie T; Shimada T; Kuwamura M; Baba E
J Am Anim Hosp Assoc; 1999; 35(6):475-81. PubMed ID: 10580906
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
18. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
19. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis.
Machherndl-Spandl S; Sega W; Bösmüller H; Germing U; Gruber Ch; Nachtkamp K; Reinecke P; Sperr WR; Wimazal F; Müllauer L; Sotlar K; Horny HP; Tüchler H; Valent P; Krieger O
Ann Hematol; 2014 Jan; 93(1):57-64. PubMed ID: 24241126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
